Melexis NV

ENXTBR:MELE Voorraadrapport

Marktkapitalisatie: €2.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Melexis Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Melexis heeft een totaal eigen vermogen van €553.6M en een totale schuld van €229.8M, wat de schuld-eigenvermogensverhouding op 41.5% brengt. De totale activa en totale passiva bedragen respectievelijk €891.1M en €337.5M. De EBIT Melexis is €260.8M waardoor de rentedekking 28.2 is. Het heeft contanten en kortetermijnbeleggingen van €38.6M.

Belangrijke informatie

41.5%

Verhouding schuld/eigen vermogen

€229.82m

Schuld

Rente dekkingsratio28.2x
Contant€38.55m
Aandelen€553.59m
Totaal verplichtingen€337.51m
Totaal activa€891.10m

Recente financiële gezondheidsupdates

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

May 22
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Jan 02
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 17
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 15
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Jun 08
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Recent updates

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Oct 01
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Aug 31
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

Aug 19
There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Aug 02
Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

A Look At The Fair Value Of Melexis NV (EBR:MELE)

Jul 04
A Look At The Fair Value Of Melexis NV (EBR:MELE)

Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Jun 20
Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Melexis (EBR:MELE) Knows How To Allocate Capital

Jun 07
Melexis (EBR:MELE) Knows How To Allocate Capital

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

May 22
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

May 08
Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Mar 27
Calculating The Fair Value Of Melexis NV (EBR:MELE)

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Mar 14
At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Feb 28
Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Feb 15
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Jan 02
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Dec 09
What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Nov 27
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Melexis (EBR:MELE) Knows How To Allocate Capital

Nov 15
Melexis (EBR:MELE) Knows How To Allocate Capital

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Nov 03
Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 10
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Sep 26
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 17
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Sep 02
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Aug 19
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Aug 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Might Become A Compounding Machine

Jul 13
Melexis (EBR:MELE) Might Become A Compounding Machine

Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Jun 29
Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

Jun 02
Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Apr 11
At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Mar 27
With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jan 09
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Dec 24
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 24
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Oct 18
Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 04
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 20
Melexis' (EBR:MELE) Dividend Will Be €0.91

We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Sep 19
We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Aug 22
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Aug 04
Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Jul 11
Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Jun 27
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Jun 13
Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Mar 01
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Feb 14
Calculating The Fair Value Of Melexis NV (EBR:MELE)

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Dec 06
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Nov 18
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 29
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 15
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around

Jul 18
Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jun 21
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Jun 08
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

Apr 11
Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €450.9M ) MELE } overtreffen de korte termijn passiva ( €95.9M ).

Langlopende schulden: De kortetermijnactiva MELE ( €450.9M ) overtreffen de langetermijnschulden ( €241.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 34.6% ) MELE wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van MELE is de afgelopen 5 jaar gestegen van 19.4% naar 41.5%.

Schuldendekking: De schuld van MELE wordt goed gedekt door de operationele kasstroom ( 66.4% ).

Rentedekking: De rentebetalingen op de schuld van MELE worden goed gedekt door EBIT ( 28.2 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y